Skip to content

Hepatic Enzymes, Psychological Measures, and Sexual Dysfunction Responses to Aerobic Exercise in Hepatitis-C Men

Is There a Response of Hepatic Enzymes, Psychological Measures, and Sexual Dysfunction to Aerobic Exercise in Men With Sexual Dysfunction Complaint and Hepatitis C

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05624086
Enrollment
46
Registered
2022-11-21
Start date
2022-10-15
Completion date
2023-04-15
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction, Hepatitis C

Brief summary

Chronic hepatitis C virus (HCV) infection is a systematic disease that affects several aspects of patients' well-being, including physical, mental, social, and sexual quality of life. In recent years, this clinical trial aims to search the Response of Hepatic Enzymes, Psychological Measures, and Sexual Dysfunction to Aerobic Exercise in Hepatitis Men With Sexual Dysfunction Complaint

Detailed description

Hepatitis Men With Sexual Dysfunction (erectile dysfunction) Complaint (n=46) will be randomized randomly to 23-men exercise-training (one hour walking on treadmill, for 3 months, three walking sessions per the week) hepatitis-C group or 23-men waiting-hepatitis-C group.

Interventions

BEHAVIORALexercise

Hepatitis-C Men With Sexual Dysfunction (erectile dysfunction) Complaint will receive exercise-training sessions (one hour walking on treadmill, for 3 months, three walking sessions per the week)

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
35 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* men with hepatitis C men diagnosis * men with sexual dysfunction (erectile dysfunction)

Exclusion criteria

* obesity , men with cardiac/thoracic/systemic diseases, drugs for sexual dysfunction (erectile dysfunction)

Design outcomes

Primary

MeasureTime frameDescription
International Index of Erectile Function (IIEF-5)It will be measured after 12 weeks of trainingit will assess the sexual dysfunction in men

Secondary

MeasureTime frameDescription
alanine transaminaseIt will be measured after 12 weeks of trainingit is an enzyme of liver will assess the liver funtions
aspartate transaminaseIt will be measured after 12 weeks of trainingit is an enzyme of liver will assess the liver funtions
Rosenberg Self-Esteem ScaleIt will be measured after 12 weeks of trainingit is a questionnaire that will assess Self-Esteem
Profile of Mood StatesIt will be measured after 12 weeks of trainingit is a questionnaire that will assess mood of men
depression inventory of BeckIt will be measured after 12 weeks of trainingit is a questionnaire that will assess depression of men

Countries

Egypt

Contacts

Primary ContactAli Ismail, lecturer
ali.mohamed@pt.cu.edu.eg02 01005154209
Backup ContactAli Ismail, Lecturer
ali.mohamed@pt.cu.edu.eg02 0103377553

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026